Immunohistochemical Detection of Cancer-Testis Antigen PRAME by Lezcano, Cecilia, Müller, Annette M., Frosina, Denise, Hernandez, Enmily, Geronimo, Jerica A., Busam, Klaus J., Jungbluth, Achim A.

Get full text

Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage by Barrow, Catherine, Browning, Judy, MacGregor, Duncan, Davis, Ian D, Sturrock, Sue, Jungbluth, Achim A, Cebon, Jonathan

Get full text

JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management by Gupta, Sounak, Cheville, John C., Jungbluth, Achim A., Zhang, Yanming, Zhang, Lei, Chen, Ying-Bei, Tickoo, Satish K., Fine, Samson W., Gopalan, Anuradha, Al-Ahmadie, Hikmat A., Sirintrapun, Sahussapont J., Blum, Kyle A., Lohse, Christine M., Hakimi, A. Ari, Thompson, R. Houston, Leibovich, Bradley C., Berger, Michael F., Arcila, Maria E., Ross, Dara S., Ladanyi, Marc, Antonescu, Cristina R., Reuter, Victor E.

Get full text

Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors by Busam, Klaus J, Pulitzer, Melissa P, Coit, Daniel C, Arcila, Maria, Leng, Danielle, Jungbluth, Achim A, Wiesner, Thomas

Get full text

Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder by Hodgson, Anjelica, Jungbluth, Achim A., Katabi, Nora, Xu, Bin, Downes, Michelle R.

Get full text

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens by Almeida, Luiz Gonzaga, Sakabe, Noboru J, deOliveira, Alice R, Silva, Maria Cristina C, Mundstein, Alex S, Cohen, Tzeela, Chen, Yao-Tseng, Chua, Ramon, Gurung, Sita, Gnjatic, Sacha, Jungbluth, Achim A, Caballero, Otávia L, Bairoch, Amos, Kiesler, Eva, White, Sarah L, Simpson, Andrew J.G, Old, Lloyd J, Camargo, Anamaria A, Vasconcelos, Ana Tereza R

Get full text

Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity by Pareja, Fresia, da Silva, Edaise M., Frosina, Denise, Geyer, Felipe C., Lozada, John R., Basili, Thais, Da Cruz Paula, Arnaud, Zhong, Elaine, Derakhshan, Fatemeh, D’Alfonso, Timothy, Wen, Hannah Y., Giri, Dilip D., Hayes, Malcolm M., Krings, Gregor, Bhargava, Rohit, Palazzo, Juan P., Rakha, Emad A., Hoda, Syed A., Sanders, Melinda E., Collins, Laura C., Schnitt, Stuart J., Chen, Yunn-Yi, Weigelt, Britta, Jungbluth, Achim A., Reis-Filho, Jorge S., Brogi, Edi

Get full text

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics by Fan, Pang-Dian, Narzisi, Giuseppe, Jayaprakash, Anitha D., Venturini, Elisa, Robine, Nicolas, Smibert, Peter, Germer, Soren, Yu, Helena A., Jordan, Emmet J., Paik, Paul K., Janjigian, Yelena Y., Chaft, Jamie E., Wang, Lu, Jungbluth, Achim A., Middha, Sumit, Spraggon, Lee, Qiao, Huan, Lovly, Christine M., Kris, Mark G., Riely, Gregory J., Politi, Katerina, Varmus, Harold, Ladanyi, Marc

Get full text

Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer by Fusco, Nicola, Geyer, Felipe C, De Filippo, Maria R, Martelotto, Luciano G, Ng, Charlotte K Y, Piscuoglio, Salvatore, Guerini-Rocco, Elena, Schultheis, Anne M, Fuhrmann, Laetitia, Wang, Lu, Jungbluth, Achim A, Burke, Kathleen A, Lim, Raymond S, Vincent-Salomon, Anne, Bamba, Masamichi, Moritani, Suzuko, Badve, Sunil S, Ichihara, Shu, Ellis, Ian O, Reis-Filho, Jorge S, Weigelt, Britta

Get full text

CytoLyt fixation significantly inhibits MIB1 immunoreactivity whereas alternative Ki‐67 clone 30‐9 is not susceptible to the inhibition: Critical diagnostic implications by Buonocore, Darren J., Konno, Fumiko, Jungbluth, Achim A., Frosina, Denise, Fayad, Mariam, Edelweiss, Marcia, Lin, Oscar, Rekhtman, Natasha

Get full text

Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma by Pulitzer, Melissa P, Brannon, A Rose, Berger, Michael F, Louis, Peter, Scott, Sasinya N, Jungbluth, Achim A, Coit, Daniel G, Brownell, Isaac, Busam, Klaus J

Get full text

Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes by Moukarzel, Lea A., Da Cruz Paula, Arnaud, Ferrando, Lorenzo, Hoang, Timothy, Sebastiao, Ana Paula Martins, Pareja, Fresia, Park, Kay J., Jungbluth, Achim A., Capella, Gabriel, Pineda, Marta, Levin, Jeffrey D., Abu-Rustum, Nadeem R., Ellenson, Lora H., Bel, August Vidal, Reis-Filho, Jorge S., Matias-Guiu, Xavier, Cadoo, Karen, Stadler, Zsofia K., Weigelt, Britta

Get full text

MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin by NARDIELLO, Tricia, JUNGBLUTH, Achim A, PEARSE, Roger, COLEMAN, Morton, JAYABALAN, David S, BHARDWAJ, Nina, OLD, Lloyd J, CHEN-KIANG, Selina, HEARN JAY CHO, MEI, Anna, DILIBERTO, Maurizio, XIANGAO HUANG, DABROWSKI, Ania, ANDRADE, Valéria C. C, WASSERSTRUM, Rebecca, ELY, Scott, NIESVIZKY, Ruben

Get full text

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma by Pollack, Seth M., Jungbluth, Achim A., Hoch, Benjamin L., Farrar, Erik A., Bleakley, Marie, Schneider, David J., Loggers, Elizabeth T., Rodler, Eve, Eary, Janet F., Conrad, III, Ernest U., Jones, Robin L., Yee, Cassian

Get full text

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma by Ott, Patrick A., Carvajal, Richard D., Pandit-Taskar, Neeta, Jungbluth, Achim A., Hoffman, Eric W., Wu, Bor-Wen, Bomalaski, John S., Venhaus, Ralph, Pan, Linda, Old, Lloyd J., Pavlick, Anna C., Wolchok, Jedd D.

Get full text

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma by Maki, Robert G, Jungbluth, Achim A, Gnjatic, Sacha, Schwartz, Gary K, D'Adamo, David R, Keohan, Mary Louise, Wagner, Michael J, Scheu, Kelly, Chiu, Rita, Ritter, Erika, Kachel, Jennifer, Lowy, Israel, Old, Lloyd J, Ritter, Gerd

Get full text

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade by Ariyan, Charlotte E, Brady, Mary Sue, Siegelbaum, Robert H, Hu, Jian, Bello, Danielle M, Rand, Jamie, Fisher, Charles, Lefkowitz, Robert A, Panageas, Kathleen S, Pulitzer, Melissa, Vignali, Marissa, Emerson, Ryan, Tipton, Christopher, Robins, Harlan, Merghoub, Taha, Yuan, Jianda, Jungbluth, Achim, Blando, Jorge, Sharma, Padmanee, Rudensky, Alexander Y, Wolchok, Jedd D, Allison, James P

Get full text

Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC) by Haidari, Selgai, Tröltzsch, Matthias, Fliefel, Riham, Jungbluth, Achim A., Otto, Sven, Fegg, Florian, Liokatis, Paris, Ahmadi, Nima, Eberl, Marian, Probst, Florian Andreas, Knösel, Thomas

Get full text

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition by Chiang, Sarah, Vasudevaraja, Varshini, Serrano, Jonathan, Stewart, Colin J. R., Oliva, Esther, Momeni-Boroujeni, Amir, Jungbluth, Achim A., Da Cruz Paula, Arnaud, da Silva, Edaise M., Weigelt, Britta, Park, Kay J., Soslow, Robert A., Murali, Rajmohan, Ellenson, Lora H., Benayed, Ryma, Ladanyi, Marc, Abu-Rustum, Nadeem R., Dickson, Mark A., Cohen, Seth, Aghajanian, Carol, Hensley, Martee L., Lee, Cheng-Han, Snuderl, Matija, Konner, Jason A.

Get full text

The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma by Dogan, Snjezana, Frosina, Denise, Fayad, Miriam, de Oliveira, Thais Basili, Alemar, Barbara, Rosenblum, Marc, Tang, Laura H., Hameed, Meera, Xu, Bin, Ghossein, Ronald A., Chute, Deborah J., Weigelt, Britta, Jungbluth, Achim A.

Get full text